Literature DB >> 19705247

Large cell neuroendocrine carcinoma of the gallbladder: long survival achieved by multimodal treatment.

Chigusa Shimono1, Kazuhiro Suwa, Morio Sato, Shintaro Shirai, Katsuyuki Yamada, Yasushi Nakamura, Masatoshi Makuuchi.   

Abstract

Large cell neuroendocrine carcinoma of the gall-bladder is a rare disease in which the prognosis worsens with size. We report a case of large cell neuroendocrine carcinoma of the gallbladder in a 64-year-old woman who presented with a right upper quadrant mass whose longest diameter was 11.5 cm; the mass was initially considered to be unresectable because of probable invasion to the main portal vein and biliary tract. The patient received multi-modal treatment, consisting of intraarterial chemotherapy, three-dimensional radiation therapy, right trisegmentectomy, and gamma-knife irradiation (for brain metastases). She has survived for 69 months since the initial diagnosis and has shown no signs of recurrence at 35 months after the last gamma-knife irradiation for brain metastases. This result suggests that multimodal treatment including surgery, chemotherapy, and radiation therapy achieved a good response and led to long survival.

Entities:  

Mesh:

Year:  2009        PMID: 19705247     DOI: 10.1007/s10147-008-0843-6

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  18 in total

1.  Large cell neuroendocrine carcinoma of the gallbladder: report of two cases.

Authors:  M Papotti; P Cassoni; A Sapino; G Passarino; J E Krueger; J Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases.

Authors:  C B Gilks; R H Young; D J Gersell; P B Clement
Journal:  Am J Surg Pathol       Date:  1997-08       Impact factor: 6.394

3.  Endocrine cell carcinoma of the gallbladder.

Authors:  C A McLean; J S Pedersen
Journal:  Histopathology       Date:  1991-08       Impact factor: 5.087

4.  Intestinal metaplasia of the gallbladder: a morphologic and immunocytochemical study.

Authors:  J Albores-Saavedra; M Nadji; D E Henson; J Ziegels-Weissman; J M Mones
Journal:  Hum Pathol       Date:  1986-06       Impact factor: 3.466

5.  A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer.

Authors:  J E Krook; J R Jett; C Little
Journal:  Am J Clin Oncol       Date:  1989-04       Impact factor: 2.339

6.  Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder.

Authors:  S Hailemariam; A Gaspert; P Komminoth; P Tamboli; M Amin
Journal:  Mod Pathol       Date:  1998-10       Impact factor: 7.842

7.  Oat cell carcinoma of the gallbladder.

Authors:  J Albores-Saavedra; J Soriano; O Larraza-Hernandez; J Aguirre; D E Henson
Journal:  Hum Pathol       Date:  1984-07       Impact factor: 3.466

8.  Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study.

Authors:  P Abenoza; C Manivel; R K Sibley
Journal:  Arch Pathol Lab Med       Date:  1986-11       Impact factor: 5.534

9.  Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates.

Authors:  D E Henson; J Albores-Saavedra; D Corle
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

Review 10.  Endocrine cell carcinoma (carcinoid) of the gallbladder.

Authors:  M Yamamoto; S Nakajo; N Miyoshi; S Nakai; E Tahara
Journal:  Am J Surg Pathol       Date:  1989-04       Impact factor: 6.394

View more
  17 in total

1.  Unusual and Aggressive Cause of Gall Bladder Mass-Neuroendocrine Tumor.

Authors:  Naveen Padmanabhan; Suhail Ahmed; Ann Kurian; P Ravishankar
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 2.  "Pure" High-Grade Large Cell Neuroendocrine Carcinoma Arising from Low- and High-Grade Dysplasia of the Gallbladder: Case Report and Review of the Literature.

Authors:  Cacey Peters; Eleanor Lewin; Tong Wu; Yukihiro Nakanishi
Journal:  J Gastrointest Cancer       Date:  2019-12

Review 3.  Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review.

Authors:  Eizaburo Sasatomi; Michael A Nalesnik; J Wallis Marsh
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

4.  Primary large cell neuroendocrine carcinoma in the common bile duct: first Asian case report.

Authors:  Sung Bae Park; Suk Bae Moon; Young Joon Ryu; Jeana Hong; Yang Hee Kim; Gi Bong Chae; Seong Kweon Hong
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma.

Authors:  Chen Chen; Lin Wang; Xi Liu; Guanjun Zhang; Yaling Zhao; Zhimin Geng
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  Rare case of a gallbladder neuroendocrine carcinoma.

Authors:  Masakuni Fujii; Hiroaki Saito; Junji Shiode
Journal:  Clin J Gastroenterol       Date:  2018-07-12

7.  Two cases of neuroendocrine carcinoma of the gallbladder.

Authors:  Hao Chen; Yan-Ying Shen; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 8.  Mixed large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder: a case report and brief review of the literature.

Authors:  Wei Liu; Lei Wang; Xiao-dong He; Cheng Feng; Xiao-yan Chang; Zhao-hui Lu
Journal:  World J Surg Oncol       Date:  2015-03-18       Impact factor: 2.754

Review 9.  Treatment options for patients with large cell neuroendocrine carcinoma of the lung.

Authors:  Akira Iyoda; Takashi Makino; Satoshi Koezuka; Hajime Otsuka; Yoshinobu Hata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-10

10.  Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome.

Authors:  Shekhar Gogna; David Samson; Mahir Gachabayov; Aram Rojas; Daniel Moritz Felsenreich; Donna Koo; Katie Gu; Luis Quintero; Kendall Ryan Miller; Asad Azim; Xiang Da Eric Dong
Journal:  Langenbecks Arch Surg       Date:  2021-07-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.